With a New Soyuz Rocket, Russia Seeks to Break Its Ukrainian Dependency Summary Russia plans to debut the Soyuz-5 medium-lift rocket in December 2025 from the Baikonur spaceport. The launch…
Summary AbbVie will acquire rights to an experimental depression drug from Gilgamesh Pharmaceuticals for up to $1.2 billion, aiming to enter the fast-growing market for psychedelic-based psychiatric treatments. The lead…
Video Platform Kick Investigated Over Streamer’s Death Summary French prosecutors have opened an investigation into the Australian video platform Kick after the death of content creator Raphaël Graven (known online…
AT&T To Buy Wireless Spectrum From EchoStar For $23 Billion Cash Summary AT&T will buy wireless licences from EchoStar for $23 billion in cash, a deal that covers “virtually every”…
Biotechs Turn to Digital Coins, Crypto to Boost Stock Prices Summary Small, cash-strapped biotech companies are increasingly pivoting into cryptocurrencies and rebranding as crypto treasury vehicles in a bid to…
Study Shows Which Vehicles Pollute the Least In Every US County Summary A University of Michigan team used a life-cycle assessment model (built on Argonne National Laboratory methods and EPA…
Class Action Lawsuit Targets Movie Ownership Summary Amazon is the target of a proposed class action filed in Washington federal court alleging the company misleads customers by advertising digital movies…
With a New Soyuz Rocket, Russia Seeks to Break Its Ukrainian Dependency Summary Russia plans to launch its new Soyuz-5 rocket in December from the Baikonur cosmodrome. The flight will…
AT&T To Buy Wireless Spectrum From EchoStar For $23 Billion Cash Summary AT&T has agreed to purchase wireless licences from EchoStar for $23 billion in cash, according to the report…
AbbVie Targets Psychedelic-Based Depression Drug Market With $1.2 Billion Deal Summary AbbVie has agreed to acquire development rights to bretisilocin from Gilgamesh Pharmaceuticals for up to $1.2 billion, including an…
